SPC154
3-{6-{[1-(2,2-díflúor-1,3-bensódíoxól-5-ýl)sýklóprópankarbónýl]amínó}-3-metýlpýridín-2-ýl}bensósýra, eða lyfjafræðilega nothæft salt þar af, eða ester forlyf þar af
Status:
VeittApplication date:
17.5.2016Application published:
15.6.2016Grant published:
15.12.2017
Max expiry date:
23.11.2030Next due date:
30.11.2026Medicine name:
OrkambiMedicine for children:
No
Timeline
Today
17.5.2016Application
15.6.2016Publication
15.12.2017Registration
23.11.2030Expires
Marketing license
IS authorization number:
EU/1/15/1059/001Date:
8.12.2015
Foreign authorization number:
EU/1/15/1059Date:
19.11.2015
Owner
Name:
Vertex Pharmaceuticals IncorporatedAddress:
50 Northern Avenue, Boston US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2404919